ClinicalTrials.gg
RecruitingNCT06852443TD-CHATUpdated May 7, 2025

Troubled-Desire & Therapeutic Chat for Reduction of CSAM Use (TD-CHAT)

An interventional study of Selfhelp modules and Therapist Chat Service in Prevention, Well Being and Sexual Behavior, sponsored by Charite University, Berlin, Germany. Recruiting at 2 sites in 2 countries. Open to participants aged 18 Years to 99 Years. Per ClinicalTrials.gov, last updated 2025-05-07.

Sponsored by Charite University, Berlin, Germany · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Primary completion was expected by Feb 2026, 7 months ago, but the record still lists the study as recruiting.
  • Started Apr 2025; still recruiting 1 year 6 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
180
Allocation
Randomized
Ages
18 Years to 99 Years
Sex
All
01

Study summary

The goal of this prospective multicentred, stratified, parallel-group superiority study is to prevent and reduce the usage of Child Sexual Abuse Material (CSAM) by a Therapist Chat Service (TCS) and Selfhelp Platform for Self-Referred Patients, mostly men with a sexual interest in children. The interventions are based on Cognitive Behavioral Therapy (CBT) principles and designed to treat the sexual behavioral disorder related with CSAM consumption.

  1. Participants in the Selfhelp modules group will show a statistically significantly higher proportion of reduction in CSAM behaviours four weeks after baseline, as compared to participants in the waitlist control group.
  2. Participants in the Selfhelp modules followed by TCS group will show a statistically significantly higher reduction of CSAM behaviours compared to participants in the Selfhelp-only and TCS-only groups, post-intervention.

Researchers will compare TCS-only-, Selfhelp-only-, Selfhelp + TCS- and Waiting group to see if if the interventions decrease CSAM use and improve mental well-being.

Participants will get web based selfhelp-modules and/or text-based chat intervention operated by trained therapists.

Read the detailed description

The study will evaluate whether the TCS intervention and Selfhelp modules, independently or combined, effectively reduce CSAM use or risk of CSAM consumption and improve mental well-being among self-referred participants.

1. Objectives 1.1 Primary objectives

  1. To compare the effectiveness in reducing CSAM behaviours between the TD only group and the waitlist group four weeks after the baseline assessment.
  2. To compare the post-intervention effectiveness in reducing CSAM behaviours of the Selfhelp modules versus TCS alone and Selfhelp modules followed by TCS.

1.2 Secondary objectives

  1. To assess the reduction in severity, time and self-rated risk of CSAM consumption among participants in the intervention groups (Selfhelp modules, TCS, or Selfhelp + TCS) compared to the waitlist control group, at post-intervention.
  2. To compare the impact of the interventions (Selfhelp modules, TCS, or Selfhelp + TCS) on mental wellbeing, in contrast to the control group, at the end of the intervention period.
  3. To evaluate the effect of the interventions (Selfhelp modules, TCS, or Selfhelp + TCS) on total sexual outlet compared with the waitlist control group after the intervention period.
  4. To identify any adverse effects associated with the interventions (Selfhelp modules, TCS, or Selfhelp + TCS).

2. Hypotheses

2.1 Primary hypothesis

  1. Participants in the Selfhelp-only modules group will show a statistically significantly higher proportion of reduction in CSAM behaviours four weeks after baseline, as compared to participants in the waitlist control group.
  2. Participants in the Selfhelp modules followed by TCS group will show a statistically significantly higher reduction of CSAM behaviours compared to participants in the Selfhelp-only and TCS-only groups, post-intervention.

2.2 Secondary hypothesis

  1. Participants in the intervention groups (Selfhelp modules, TCS, or Selfhelp + TCS) will show a statistically significant reduction in the severity, time and self-rated risk of CSAM consumption compared to participants in the waitlist control group, four weeks after the initial intervention. Among the intervention groups, it is expected that the Selfhalp + TCS group will show the greatest reduction in CSAM consumption, followed by the TCS group and then the Selfhelp-only group.
  2. Participants in the intervention groups (Selfhelp modules, TCS, or Selfhelp + TCS) will show a statistically significant improvement in their mental well-being (measured using the Warwick-Edinburgh Mental Wellbeing scale). compared to participants in the waitlist control group, at post-intervention. Among the intervention groups, the Selfhelp + TCS group is expected to show the greatest improvement, followed by the TCS group, and then the Selfhelp-only group.
  3. Participants in the intervention groups (Selfhelp modules, TCS, or Selfhelp + TCS) will show a statistically significant reduction in total sexual outlet (measured using a self-reported measure) compared to participants in the waitlist control group, after the intervention. Among the intervention groups, the Selfhelp + TCS group is expected to show the greatest reduction, followed by the TCS group, and then the Selfhelp-only group.
  4. All intervention groups (Selfhelp modules, TCS, or Selfhelp + TCS) will experience adverse effects (psychological and emotional distress) to a similar extent, with no significant differences in the number or type of adverse effects reported. Adverse effects are expected to primarily involve mild to moderate psychological and emotional distress, such as feelings of anxiety or frustration, but are not expected to lead to severe distress or long-term harm.

3.Trial design

This is a prospective, randomised, multicentre, open-label, parallel-group, superiority trial designed to compare stratified, pair-matched CSAM users across three intervention groups and one wait-list control group, with an allocation ratio of 1:1:1:1. Following participant agreement to the terms of the study, demographic information, measures for stratified randomization, and baseline outcome data will be collected. Additionally, data collected from the four groups Selfhelp modules, TCS, Selfhelp + TCS, and waitlist) of the TD-CHAT study will be compared with data from a fifth group (waitlist + TCS) sourced from the "Scalable Technology for Online Prevention of Child Sexual Abuse and Child Sexual Abuse Materials" (STOP-CSAM) project.

02

Conditions studied

  • Prevention
  • Well Being
  • Sexual Behavior
  • Behavior Change
  • Behavior Problems
  • Behavior Change Interventions
  • Child Sexual Abuse Material (CSAM) Consumption
  • Behavioral Disorder
  • Online Behaviour

Keywords

  • Child Sexual Abuse Material (CSAM) consumption
  • CSAM
  • Child Sexual Abuse
  • Digital online intervention
  • CSA
  • CBT
  • iCBT
  • Cognitive Behavioural Therapy
  • Pedophilia
  • chat Intervention
03

In context

Sexual Behavior

52 studies on the registry are indexed under Sexual Behavior; 21 are open to participants now.

This study's planned enrollment of 180 is below the median of 234 across 43 interventional studies indexed under Sexual Behavior.

Browse Sexual Behavior studies →

Lead sponsor

Charite University, Berlin, Germany is the lead sponsor of 854 studies on the registry; 127 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 99 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adult participant (≥18 years);
  • recent (last 2 weeks) CSAM use or past CSAM use and self-reported risk;
  • proficiency in English, German or Spanish;
  • voluntary participation and agreement to the terms of the study.

Exclusion criteria

Exclusion Criteria:

  • Severe neuropsychiatric comorbidities (unstable psychotic disorder, organic brain damage, diminished intellectual functioning, untreated drug or alcohol addiction);
  • history of contact CSA perpetration (past or present);
  • ongoing criminal investigation, trial, punishment, or probation status for online or offline CSA or CSAM use;
  • current inpatient psychiatric treatment or other concurrent treatment targeting CSAM behaviours
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
180 participants (estimated)

Study arms

  • Experimental
    Selfhelp+TCS

    Selfhelp modules followed by Therapist Chat Service

    Behavioral: Selfhelp modules · Behavioral: Therapist Chat Service

  • Active comparator
    Selfhelp modules

    Selfhelp modules only

    Behavioral: Selfhelp modules

  • Active comparator
    TCS only

    4-6 Sessions text message-based Therapist Chat Service only

    Behavioral: Therapist Chat Service

  • No intervention
    Waitlist

    Participants will remain on a waitlist for the first two weeks without receiving any kind of intervention.

Interventions

  • BehavioralSelfhelp modules

    16 web-based structured selfhelp modules, based on CBT techniques from the Berlin Dissexuality Therapy (Beier, K. M. (2021). Pedophilia, hebephilia and sexual offending against children. The Berlin Dissexuality Therapy (BEDIT). Springer)

  • BehavioralTherapist Chat Service

    Online Therapy Chat Service (TCS) based on CBT techniques from the Berlin Dissexuality Therapy (Beier, K. M. (2021). Pedophilia, hebephilia and sexual offending against children. The Berlin Dissexuality Therapy (BEDIT). Springer)

06

What researchers measure

Primary outcomes

  1. Reduction in Child Sexual Abuse Material (RCSAM) severity

    A) Reduction in Child Sexual Abuse Material severity (RCSAM severity): A reduction in CSAM severity in the last 2 weeks, defined as the pre-post difference in highest "Combating Paedophile Information Networks in Europe" (COPINE) scale scores, with a reduction from severity levels 4 or higher to levels 3 or lower after the intervention.

    Time frame: every 2 weeks for 12 weeks after onboarding

  2. Reduction in Child Sexual Abuse Material (RCSAM) time

    B) Reduction in Child Sexual Abuse Material time (RCSAM time): A 50% or greater decrease in CSAM consumption time (minutes) over the past 2 weeks. CSAM time is measured as the time (in minutes) spent consuming CSAM materials over the past 2 weeks.

    Time frame: every 2 weeks for 12 weeks after onboarding

  3. Reduction in Child Sexual Abuse Material (RCSAM) risk

    C) Reduction in self-reported risk of Child Sexual Abuse Material use (RCSAM risk): A reduction in self-reported risk of CSAM use (RCSAM risk): A decrease in the risk of CSAM consumption over the last 2 weeks, defined as a pre-post decrease in self-reported risk, as measured using an adapted version of the "Sexual Child Molestation Risk Assessment" (SChiMRA+) Part A.

    Time frame: every 2 weeks for 12 weeks after onboarding

Secondary outcomes

  1. Risk of Child Sexual Abuse Material (CSAM) consumption

    Risk of CSAM consumption: Sexual Child Molestation Risk Assessment (SchiMRA+ part A) at baseline and follow-up.

    Time frame: baseline and 12 weeks after onboarding

  2. Frequency of Child Sexual Abuse Material (CSAM) consumption

    Frequency of Child Sexual Abuse Material (CSAM) consumption: Self-reported every two weeks, at baseline and follow-up.

    Time frame: baseline and every 2 weeks for 12 weeks after onboarding

  3. Mental Wellbeing

    Mental wellbeing: The Warwick-Edinburgh Mental Wellbeing Scale (WEMBWS; Tennant et al., 2007). The total score is obtained by summing the score for each of the 14 items. The scoring range for each item is from 1 - 5 and the total score is from 14-70. Higher scores mean a better outcome. Mental wellbeing is measured over the past 2 weeks.

    Time frame: baseline and every 2 weeks during 12 weeks after onboarding

  4. Total Sexual Outlet

    1. Self-reported number of orgasms achieved from masturbation using Child Sexual Abuse Material (CSAM) in the past week 2. Self-reported number of orgasms achieved from masturbation not using CSAM in the past week 3. Self-reported number of orgasms achieved from sexual interaction in the past week 4. Total sexual outlet: sum of self-reported number of orgasms from masturbation (with and without using CSAM) + self-reported number of orgasms from sexual interaction. This outcome is measured at baseline and follow-up.

    Time frame: baseline and every 2 weeks during 12 weeks after onboarding

07

Study locations

1 of 2 sites recruiting
  • Charité Universitätsmedizin Berlion
    Berlin, 10117, Germany
    Recruiting
  • Universitat Internacional de Catalunya (UIC), Catalonia, Spain
    Barcelona, Spain
    Not yet recruiting
08

References and documents

Publications

  • Landgren V, Malki K, Bottai M, Arver S, Rahm C. Effect of Gonadotropin-Releasing Hormone Antagonist on Risk of Committing Child Sexual Abuse in Men With Pedophilic Disorder: A Randomized Clinical Trial. JAMA Psychiatry. 2020 Sep 1;77(9):897-905. doi: 10.1001/jamapsychiatry.2020.0440. PubMed 32347899 ↗
  • Merdian HL, Moghaddam N, Boer DP, Wilson N, Thakker J, Curtis C, Dawson D. Fantasy-Driven Versus Contact-Driven Users of Child Sexual Exploitation Material: Offender Classification and Implications for Their Risk Assessment. Sex Abuse. 2018 Apr;30(3):230-253. doi: 10.1177/1079063216641109. Epub 2016 Apr 6. PubMed 27052851 ↗
  • Tennant R, Hiller L, Fishwick R, Platt S, Joseph S, Weich S, Parkinson J, Secker J, Stewart-Brown S. The Warwick-Edinburgh Mental Well-being Scale (WEMWBS): development and UK validation. Health Qual Life Outcomes. 2007 Nov 27;5:63. doi: 10.1186/1477-7525-5-63. PubMed 18042300 ↗
  • Quayle, E. (2008). The COPINE project. Irish Probation Journal, 5(9), 65-83.

Individual participant data

Plan to share: Yes

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Apr 2025 (actual). Primary completion is estimated for Feb 2026, 10 months after the start.

Of 31 interventional studies with no phase under Sexual Behavior, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 15 and three quarters within 59. This study's planned 10 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 19, 2025
First posted
Feb 28, 2025
StartActual
Apr 1, 2025
Primary completionEst.
Feb 28, 2026
CompletionEst.
Jul 31, 2026
Last update
May 7, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 7, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06852443
Responsible party
Hannes Gieseler (Dipl.Des., Charite University, Berlin, Germany) — Principal investigator
First posted
Feb 28, 2025
Start date
Apr 1, 2025
Primary completion
Feb 28, 2026 (estimated)
Completion
Jul 31, 2026 (estimated)
Last update
May 7, 2025

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion